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1682-606X/Copyright ª 2015, TaiwanSummary Toxic epidermal necrolysis (TEN) is a life-threatening skin reaction associated with
a high mortality rate. Most TEN is induced by drugs, but some cases are caused by other insults.
Mycoplasma pneumoniae and herpes simplex virus are the most common infectious pathogens
associated with TEN. In identifying the etiology of TEN, it is crucial to include not only a
detailed drug history but also potential infection sources. Any suspicious infections should
be treated in a timely and efficient manner to improve survival rates. In this article, we report
on five patients who developed TEN related to M. pneumoniae and herpes simplex virus infec-
tions. We also reviewed the relevant literature. We performed a retrospective medical chart
review of five patients with TEN, which was considered secondary to M. pneumoniae and her-
pes simplex virus infections. We compared patients with infection-induced and drug-induced
TEN. We found that patients with infection-induced TEN were younger in age and had lower
SCORTEN scores, less renal dysfunction, shorter hospitalization periods, and higher survival
rates compared with patients with drug-induced TEN. Identifying the etiology of TEN
requires the inclusion of not only a detailed drug history but also infection sources, such as
M. pneumoniae and herpes simplex virus. Our findings corroborate previously reported clinicalauthors have any financial interest in any of the products, devices, or drugs mentioned in this
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38 C.-H. Hu et al.and etiologic association with TEN. TEN induced by M. pneumoniae and herpes simplex virus
manifested less severe clinical courses than its drug-induced counterpart.
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reserved.1. Introduction
Toxic epidermal necrolysis (TEN) and StevenseJohnson syn-
drome (SJS) are uncommon but life-threatening skin condi-
tions. Skin detachment of < 10% of total body surface area
(TBSA) is classified as SJS, > 30% detachment is classified as
TEN, and between 10% and 30% detachment is classified as
overlap SJS/TEN.1,2 Most TEN has an acute onset and is a
result of an adverse drug reaction. However, other condi-
tions, such as infections, can also be a trigger. Of the 101
patientswith TEN in our previous study, five patients had TEN
caused by infection.3 Of these five patients, three had TEN
associated with Mycoplasma pneumoniae and two had TEN
associated with herpes simplex virus infection.
M. pneumoniae is a well-known cause of SJS, which is an
intracellular pathogen responsible for atypical respiratory
infection. It hasbeen reportedas themost common infectious
agent associated with SJS affecting children and young
adults.4 It is rarely thecauseofTEN.5e7Herpes simplexvirus is
located in the basal keratinocyte and lower spinous cell
layers. Expression of viral DNA fragments in the keratinocyte
layer leads to activation of CD4 positive T-helper cells, which
induce various reactions, including cytokine production and
subsequent inflammatory response. CD4 positive T-helper
cells are also the predominant cells in the blister fluid of pa-
tientswithTEN,8 and thecytokine theyproduce is responsible
for the pathologic findings in skin lesions.9 It is crucial that an
etiology of TEN includes not only a detailed drug history but
also infection sources. In this article, we report on five pa-
tients inwhomTENdevelopedbecause ofM.pneumoniae and
herpes simplex virus infections, and we review the relevant
literature. Additionally, we compare patients with TEN
associated with viral infections and patients with drug-
induced TEN.2. Patients and methods
A retrospective medical chart review was performed for
five patients admitted between January 1992 and
December 2009 to a burn intensive care unit (BICU) with
TEN, which was considered secondary to M. pneumoniae
and herpes simplex virus infections.
The severity of TEN was measured using the patients’
SCORTEN scores. The SCORTEN (Severity-of-Illness Score for
Toxic Epidermal Necrolysis) score is an illness severity index
used exclusively for TEN developed by Roujeau in 2000 and
is defined by the EuroSCAR group.11 The score is designed to
predict the mortality rate through seven independent fac-
tors that are scored within 24 hours from patient admission
(Table 1). Each factor contributes one point to the overall
SCORTEN level, with a higher score correlating with ahigher mortality rate. The treatment protocol that was
applied for these patients with infection-induced TEN was
the same as the protocol for patients with drug-induced
TEN. Early diagnosis, prompt withdrawal of suspected
drugs, and confirmation of possible infection sources were
considered the most critical to manage this condition. Fluid
resuscitation was begun after admission according to body
surface defect percentage and adjusted according to urine
output. Hydrotherapy was administered to all patients to
remove the lytic skin carefully. Membrane dressings were
used for wound care. Aquacel Ag Hydrofiber dressing
(Convatec Inc. USA) or Acticoat (Smith & Nephew, Inc.)
USA was used routinely for both patients with drug- and
infection-induced TEN. These were most effective for
children because of their poor cooperation and compliance
when changing dressing. Elastic cotton bandages were then
wrapped around the dressing. The dressing is changed every
2e3 days. The wound was evaluated twice per week; all
dressings were removed and hydrotherapy was performed.
Efficacy was determined by measuring wound healing time
to achieve 95% re-epithelialization of the involved area.
The database from our previously published study3 was
used for comparisons between patients with infection- and
drug-induced TEN, such as severity, length of hospitaliza-
tion periods, and prognosis. All demographic data,
including sex, age, TBSA, and SCORTEN score, and labora-
tory data and outcome were obtained. In this study, renal
dysfunction was defined as serum creatinine 1.5 times that
of known baseline or urine production of < 0.5 mL/kg for 6
hours according to the International Consensus Conference
of the Acute Dialysis Quality Initiative (ADQI) Group.10
2.1. Statistical analysis
Values were expressed as mean  standard deviation.
Categorical and continuous variables were compared with
means and normal distributions using the Chi-square and
ManneWhitney U tests. Any p value < 0.05 were considered
statistically significant.3. Results
Three cases were diagnosed as TEN associated with M.
pneumoniae and two were diagnosed as TEN associated
with herpes simplex virus infection (Table 2). The presence
of these viruses was confirmed by positive serologic find-
ings. The patients consisted of three boys and two girls,
with an average age of 8.6 years (range 6e12 years). All
cases were referred to the BICU at the acute stage with an
average duration from disease onset of 4.2  3.1 days. The
average rate of TBSA epidermal detachment among our
Table 1 SCORTEN: Seven independent prognostic factors
for StevenseJohnson syndrome and toxic epidermal
necrolysis.
Independent prognostic factor Weight
Age  40 y Yes Z 1; No Z 0
Associated malignancya Yes Z 1; No Z 0
Detached or compromised
body surface
 10% Yes Z 1; No Z 0
Heart rate (beats/min)  120/min Yes Z 1; No Z 0
Serum urea (mg/dL) > 28 Yes Z 1; No Z 0
Serum glucose (mg/dL) > 252 Yes Z 1; No Z 0
Serum bicarbonate (mEq/L) < 20 Yes Z 1; No Z 0
SCORTEN sum of scoreb Mortality rate (%)
0e1 3.2
2 12.1
3 35.3
4 58.3
 5 > 90
SCORTEN Z Severity-of-Illness Score for Toxic Epidermal
Necrolysis.
a Associated malignancy: evolving cancer and hematological
malignancies.
b In the SCORTEN Scale, 7 independent risk factors for high
mortality are systematically scored so as to determine the
mortality rate for that particular patient.
Toxic epidermal necrolysis 39patients was 55  30.7%. The average SCORTEN score
recorded on admission was 1.10 All patients survived. The
average hospital stay of survived patients was 16.2 days
(range 10e24 days). According to our database, there were
62 patients with drug-induced TEN. A younger age (infec-
tion-induced TEN:drug-induced TEN Z 8.6:61.8, p < 0.05);
lower SCORTEN score (infection-induced TEN:drug-induced
TEN Z 1: 3.0, p < 0.05); less renal dysfunction (infection-
induced TEN:drug-induced TEN Z 0%:32.3%, p < 0.05);
shorter hospitalization period (infection-induced TEN:drug-
induced TEN Z 16.2:22.1, p < 0.05); and higher
survival rate (infection-induced TEN:drug-induced
TEN Z 100%:48.4%, p < 0.05) were noted in patients with
infection-induced TEN (Table 3). Infection-induced TEN
manifests a less severe clinical course than its drug-induced
counterpart.
3.1. Case 1
The patient, a 6-year-old girl, presented with a 4-day his-
tory of productive cough, headache, fever, and malaise.
She was admitted to our pediatric ward on the 5th dayTable 2 Patient with toxic epidermal necrolysis associated with
Case no. Age (y) Sex Cause TBSA of
eruption
1 12 F Mycoplasma pneumonia infection 90
2 6 F Mycoplasma pneumonia infection 95
3 8 M Mycoplasma pneumonia infection 30
4 8 M Herpes simplex virus infection 30
5 9 M Herpes simplex virus infection 30
TBSA Z total body surface area.because of a high fever of 41.6C. The patient and family
denied any drug history. One day later, severe generalized
erythematous skin rashes with multiple bullaes developed,
covering 95% of the patient’s TBSA. Dermatologic consul-
tation was performed and a diagnosis of TEN was consid-
ered. The patient’s SCORTEN score was 1. The patient was
transferred to our BICU because of the progression of her
clinical condition. In the BICU, a physical examination
revealed her blood pressure was 150/100 mmHg, her pulse
rate was 116 beats/min, her respiratory rate was 24 times/
min, and she had developed a high spiking fever of 41C
body temperature. The patient’s chest auscultation was
normal. We observed bilateral nonpurulent conjunctivitis,
consulted an ophthalmologist, and administered topical
antibiotics. Additionally, erosions and bullae covering the
entire buccal mucosa, tongue, and lip were noted. Gener-
alized tender erythematous macules, which progressed to
blisters and denudation accompanied by the Nikolsky sign
were also observed (Fig. 1). A chest X-ray revealed promi-
nent peribronchial cuffing and bilateral lower lung field
infiltration (Fig. 2). Blood, sputum, and urine cultures were
all negative. However, a M. pneumoniae-immunoglobulin
IgM test was strongly positive, but on transfer to the burn
ICU, an IgG serologic test was negative, demonstrating
recent infection. A skin biopsy showed total detachment,
necrosis, and dyskeratosis of the epidermis with mild per-
ivascular mononuclear cell infiltrates in the dermis (Fig. 3).
We then made a diagnosis of TEN. In the following days,
antimicrobial therapy with erythromycin (250 mg twice per
day) was prescribed. The wound was covered by Acticoat
(Smith & Nephew, Inc.) (Fig. 4). The condition improved
each day after treatment. Eight days later, the wound
became dry and a new skin island appeared. After 2 weeks,
the entire wound had healed (Fig. 5). M. pneumoniae-IgG
was then converted to positive and M. pneumoniae-IgM was
within normal limit in serologic test. The patient survived
and was discharged without complication 20 days after
admission.
3.2. Case 2
A 7-year-old boy complained of lip swelling with crust for-
mation for 5 days and a generalized erythematous skin rash
with bullae for 4 days. His mother noted several vesicles
over his upper lip and commissure after several oral aph-
thae had developed and his condition had deteriorated; the
patient was referred to our hospital. On admission, he
exhibited skin eruptions with bullae and erythema on his
face and extremities, bilateral conjunctivitis, and oral ul-
cers. Thirty percent of his TBSA was affected. Nikolsky signmycoplasma pneumonia and herpes simplex virus infection.
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40 C.-H. Hu et al.was noted. His temperature was 38.8C. His mother denied
any previous drug history. Laboratory investigation
revealed a normal result for complete blood count, differ-
ential, urinalysis, liver and renal function tests, electro-
lytes, and coagulation studies. However, his C-reactive
protein (CRP) level was elevated to 11.9 mg/dL. His anti-
bodies against varicella zoster virus and mycoplasma
pneumonia did not increase; however, a test for herpes
simplex virus-IgM was strongly positive. A dermatologist
made a diagnosis of TEN and an associated viral infection.
Therefore, the patient was transferred to our BICU on the
5th day of his hospital admission. His SCORTEN score was 1.
The wound was covered with Aquacel Ag Hydrofiber
dressing (Convatec Inc. USA). Additionally, topical treat-
ment with acyclovir was prescribed. His condition gradually
improved. On Day 13, the wound became dry and a new skin
island appeared. His herpes simplex virus-IgM returned to
the normal range, and his herpes simplex virus-IgG was
positive. He was then transferred to a general ward and
discharged 2 days later.4. Discussion
TEN is a rare but life-threatening disorder, with an inci-
dence estimated at 0.4e1.3 cases per million person-
years.2,12 TEN is an acute condition that often results from
an adverse drug reaction. The drugs linked to the majority
of patients with TEN include anticonvulsants, nonsteroidal
anti-inflammatory drugs, allopurinol, and some antibi-
otics.3 However, other conditions, such as infections, can
also act as a trigger. In previous studies, several viral in-
fections have been reported to be associated with TEN,
such as the EpsteineBarr virus, cytomegalovirus, human
herpes virus-6, herpes simplex virus, and human immuno-
deficiency virus.12,13
According to the literature, most skin reactions caused
by M. pneumoniae and herpes simplex virus infections are
associated with less frequent and less severe complications
than those with other causes. The outcome and prognosis
are typically favorable with no permanent complica-
tions.4,14 In this study, three cases were due to M. pneu-
moniae, and two were due to a herpes simplex virus
infection, as confirmed by a positive serologic finding. We
found that the five patients with infection-induced TEN
were younger in age and had lower SCORTEN scores, less
renal dysfunction, shorter hospitalization periods, and
higher survival rates compared with patients with drug-
induced TEN.
According to our results, TEN in adults is typically caused
by a drug, whereas TEN in children is typically caused by an
infection. The mean age of those with infection-related
TEN was 8.6  1.9 years, whereas the mean age of those
with drug- induced TEN was 61.8  19.8 years. Older age
was one risk factor for a poor prognosis. Roujeau et al re-
ported patients older than 40 years had a greater risk of
death because of higher rates of underlying disease and
immunodeficiency.11
The average SCORTEN score for patients with infection-
induced TEN was 1. The predicted mortality rate by
SCORTEN score was 3.2%.11 The actual mortality rate in our
series was 0%. No permanent complications were noted.
Figure 1 Patient with toxic epidermal necrolysis related to Mycoplasma pneumoniae infection. Generalized erythematous
macules and blisters over about 95% of total body surface area, including the lip and oral mucosa.
Figure 2 Chest X-ray plain film on the 1st day after admis-
sion revealed peribronchial thickening.
Toxic epidermal necrolysis 41In the current study, the SCORTEN scores among patients
with infection-induced TEN was 1, whereas the SCORTEN
score among patients with drug-induced TEN was 3, which
implies that the patients with infection-induced TEN had
superior outcomes compared with those with drug-induced
TEN.
No renal dysfunction was found in the patients with
infection-induced TEN; however, a 32.3% rate of renal
dysfunction was noted in the patients with drug-induced
TEN. The higher mortality rate among the patients withdrug-induced TEN may be attributable to a higher rate of
renal failure compared with those with infection-induced
TEN. The aforementioned higher rates of renal failure are
likely a result of the tendency in Chinese society to use
Chinese medication or herbs or multiple drugs instead of
seeking medical assistance. This tendency can compound
problems, substantially impair renal function, and deteri-
orate a patient’s general condition.3 In our previous study,
we observed that kidney dysfunction is one of the most
crucial factors affecting outcome in patients with TEN.3 A
higher renal dysfunction rate is a likely explanation for
lower survival rates among patients with drug-induced TEN
compared with those with infection-induced TEN.
The treatment of TEN poses a great challenge because of
the rapid onset and progression of skin exfoliation with
sepsis. Unfortunately, even with the advances in modern
medicine, including improvements in intensive care,
development of new dressing material and systemic ther-
apies such as glucocorticoid and intravenous Ig, the mor-
tality rate for TEN is still high and definitive treatments for
TEN remain controversial. No optimal treatment protocol
exists for TEN. In our BICU, no differences exist between
the protocols for initial resuscitation for patients with drug-
and infection-induced TEN. Continuous monitoring ensures
adequate treatment of fluid and electrolyte imbalance as
well as local and systemic infection. Interdisciplinary
cooperation between dermatologists, ophthalmologists,
intensive care physicians, and burn surgeons is also critical.
Early confirmation of the causative agent of TEN is a crucial
step for superior prognosis of infection-induced TEN
because it enables the early prescription of antiviral drugs
to stop severe cutaneous reactions. According to a recent
study, pathogens are increasingly being identified as
Figure 3 (A) Histopathology of toxic epidermal necrolysis showed that the epidermis is separated from the underlying dermis
(black arrow; hematoxylin & eosin, 40). (B) At higher magnification, the denuded dermis revealed dyskeratosis of the epidermis
with mild perivascular mononuclear cell infiltrates in the dermis (hematoxylin & eosin, 400).
Figure 4 The wound was treated with Acticoat.
Figure 5 All wounds had almost healed by Day
42 C.-H. Hu et al.causative agents for severe mucocutaneous blistering re-
actions mimicking life-threatening severe cutaneous
adverse reactions.15 Any diagnosis or treatment delay
causes a severe cutaneous adverse reaction to eventually
progress to SJS or TEN.
One major drawback of this study is that the sample size
of patients with infection-induced TEN (n Z 5) was too
small for the results to be considered statistically signifi-
cant. Despite the small sample size, comparative analysis
was performed between patients with drug-induced TEN
and those with infection-induced TEN. In this regard, the
results are obvious and the first of their kind in Taiwan.
In conclusion, identifying the etiology of TEN requires
the inclusion not only of a detailed drug history, but also
the infection sources, including M. pneumoniae and herpes
simplex virus. Our findings corroborate previous reports on
the clinical and etiologic associations of TEN. M. pneumo-
niae and herpes simplex induced TEN manifested less
severely than its drug-induced counterpart.8, except for those on bilateral lower limbs.
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